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INTRODUCTION 
Diarrhoea is a very common adverse drug reaction 
following antibiotic intolerance. Antibiotic induced 
diarrhoea occurs in about 5-30% of patients either 
early during antibiotic therapy or within few months 
after the end of the treatment.1-3 The prevalence of 
antibiotic-associated diarrhea across the globe has 
increased dramatically with the increase in use of 
antibiotics.4 Countless preventive approaches to 
antibiotic-associated diarrhea have been studied. 
There is a concern that frequent use of powerful 
antibiotics has led to a vicious circle, in which the 
use of antibiotics has reduced the effectiveness of 
traditional antibiotics for C. difficile, and antibiotic-
resistant C. difficile has emerged as a global public 
health issue.4  
 
CASE PRESENTATION 
A 32-year-old woman presented with the chief 
complaint of diarrhea. She suffered from frequent 
bowel movements and lower abdominal pain and 
tenderness.  Diarrhea was bloody and mucous while 
the lower abdominal pain was cramping in nature. A 
few months back she has been treated with 
amoxicillin, clarithromycin and omeprazole 
eradication therapy for Helicobacter pylori 
infection. There was no other relevant medical or 
personal history. Except these antibiotics the patient 
had not taken any drug in the past few months. No 
concomitant medication or concurrent condition 
was reported by the patient. A few months later, she 
developed frequent bowel movements and 
hematochezia. Oral intake of food and drinks was 
poor. Fever and bloating of abdomen were also 
evident. All other vital signs were normal. Her white 
blood    cell      count  was 14,100/mm3   with   56.7%  
 
segmented neutrophils. Sigmoidoscopy revealed 
multiple yellowish plaque lesions from the rectum to 
the sigmoid colon and mucosal biopsy from the 
sigmoid colon showed chronic inflammation with 
mucous exudates. A diagnosis of 
pseudomembranous colitis (PMC) was considered.  
Faeces examination for C. difficile was positive for 
glutamate dehydrogenase although no toxins were 
present.  Treatment was started with vancomycin.  
However, due to inappropriate schedule of drug 
intake and missing doses frequently, her diarrhea 
and pain continued to worsen. She was started on 
metronidazole 500 mg three times daily along with 
intravenous fluid and electrolytes. In turn, the 
gastrointestinal symptoms were ameliorated by 
metronidazole. Hemorrhagic stool disappeared 
within 10 days. Diarrhea gradually regressed and 
overall condition improved. Feces examination 
changed to GDH negative few 4 weeks after 
treatment with metronidazole. The patient finished 
the treatment course and her symptoms did not 
recur. The only metronidazole related adverse 
events were metallic taste and nausea. However, no 
action was taken for the same and the therapy was 
continued.  
 
DISCUSSION 
There is increased demand for antibiotic therapy 
and antibiotics are now used around the world. The 
increased use of antibiotics alters the balance of the 
intestinal flora and causes dysbiosis.  This also 
induces many complications including 
pseudomemranous colitis. Clostridium difficile 
infection can be blamed for nearly all the cases of 
PMC.  The incidence of C. difficile-associated 
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diarrhea seems to be increased by acid-suppressing  
drugs such as proton pump inhibitors. Thus, the 
causal temporal relationship between omeprazole 
and pseudomembranous colitis cannot be ruled out. 
Host factors for antibiotic associated diarrhoea 
include old age and suppressed immune system.5 
Collectively, CDI appears to increase after 
eradication of H. pylori infection.6 We also had a 
patient with CDI after H. pylori eradication. The 
newest antibiotics and therapeutic approaches such 
as faecal microbial transplantation are difficult to 
implement. Almost any antibiotic may cause C. 
difficile infection, but the broad-spectrum 
antibiotics with activity against enteric bacteria are 
the most frequent causative agents.7 
 
The clinical manifestations of pseudomembranous 
colitis usually appear as diarrhea, hematochezia, 
lower abdominal pain, pyrexia and leukocytosis, but 
severe diarrhea can lead to medically significant 
complications like dehydration, electrolyte loss and 
imbalance, hypoalbuminemia, shock, acidosis and 
generalized oedema. Rarely, the affected patients 
can have life-threatening or fatal complications like 
toxic megacolon, necrotizing colitis, colon 
perforation, acute kidney injury, systemic 
inflammatory response syndrome, sepsis and death.8 
Endoscopic findings usually reveal an elevated 
yellowish pseudomembrane that is localized to 
rectum and sigmoid colon. Histologically, this 
pseudomembrane is composed of debris from 
epidermis, fibrinoid material and leukocytes and 
mucosal infiltration of leukocytes.9  
 
Antibiotic associated diarrhoea results from 
disruption equilibrium of the gut microflora. 
Antibiotics disturb the composition and the 
function of this flora and enable overgrowth of 
micro-organisms that induce diarrhoea. Clostridium 
difficile has emerged as the major enteropathogen of 
antibiotic associated diarrhoea.3 Secretion of potent 
toxins by this pathogen causes mucosal damage and 
inflammation of the colon. Other infectious agents 
reported to be responsible for antibiotic associated 
diarrhoea include Clostridium perfringens, 
Staphylococcus aureus, Klebsiella oxytoca, candida 
and Salmonella species. Antibiotic associated 
diarrhoea can also result from a decrease in 
metabolism of carbohydrates and bile acids.10 
 
Management   depends   on  the  clinical  signs   and  
 
 
symptoms   and  also   the  causative agent. In   non- 
serious cases, conventional measures include 
rehydration or discontinuation of the suspect drug. 
The primary or first line treatment regimen of 
Clostridium difficile related diarrhoea focuses on 
oral metronidazole or oral vancomycin. The uses of 
probiotics due to their benefits are unproved and are 
still a debated topic of research as few have been 
evaluated in double blind placebo controlled 
studies. The results of the small and open trials of 
treatment are not yet clear. 
 
CONCLUSION 
The prime measure for prevention of antibiotic 
associated diarrhoea and pseudomembraous colitis 
is to limit the use of antibiotics. The decision to 
continue, change, or discontinue antibiotics in a 
patient with these adverse events should depend on 
how severe are the symptoms and how much is the 
need for further antibiotic therapy to treat the 
underlying indication. Probiotics have proved useful 
in preventing diarrhoea, but the number of clinical 
trials is limited. When a patient complains 
gastrointestinal disturbances like frequent diarrhea 
with abdominal pain, the concerned healthcare 
personnel should include PMC in the differential 
diagnosis.  
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